Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
2021 2
2022 6
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workers.
Nugent C, Abul Y, White EM, Shehadeh F, Kaczynski M, Oscar Felix L, Ganesan N, Oyebanji OA, Vishnepolskiy I, Didion EM, Paxitzis A, Sheehan ML, Chan PA, Pfeifer WM, Dickerson E, Kamojjala S, Wilson BM, Mylonakis E, King CL, Balazs AB, Canaday DH, Gravenstein S. Nugent C, et al. Among authors: sheehan ml. Vaccine. 2023 May 22;41(22):3403-3409. doi: 10.1016/j.vaccine.2023.04.034. Epub 2023 Apr 24. Vaccine. 2023. PMID: 37117056 Free PMC article.
Cross-reactive SARS-CoV-2 epitope targeted across donors informs immunogen design.
Hauser BM, Feldman J, Sangesland M, Ronsard L, St Denis KJ, Sheehan ML, Cao Y, Boucau J, Windsor IW, Cheng AH, Vu ML, Cardoso MR, Kannegieter T, Balazs AB, Lingwood D, Garcia-Beltran WF, Schmidt AG. Hauser BM, et al. Among authors: sheehan ml. Cell Rep Med. 2022 Dec 20;3(12):100834. doi: 10.1016/j.xcrm.2022.100834. Epub 2022 Nov 15. Cell Rep Med. 2022. PMID: 36423634 Free PMC article.
BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in children.
Bartsch YC, Chen JW, Kang J, Burns MD, St Denis KJ, Sheehan ML, Davis JP, Edlow AG, Balazs AB, Yonker LM, Alter G. Bartsch YC, et al. Among authors: sheehan ml. NPJ Vaccines. 2022 Dec 3;7(1):158. doi: 10.1038/s41541-022-00575-w. NPJ Vaccines. 2022. PMID: 36463314 Free PMC article.
Durability and Cross-Reactivity of SARS-CoV-2 mRNA Vaccine in Adolescent Children.
Burns MD, Boribong BP, Bartsch YC, Loiselle M, St Denis KJ, Sheehan ML, Chen JW, Davis JP, Lima R, Edlow AG, Fasano A, Balazs AB, Alter G, Yonker LM. Burns MD, et al. Among authors: sheehan ml. Vaccines (Basel). 2022 Mar 23;10(4):492. doi: 10.3390/vaccines10040492. Vaccines (Basel). 2022. PMID: 35455241 Free PMC article.
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant.
Garcia-Beltran WF, St Denis KJ, Hoelzemer A, Lam EC, Nitido AD, Sheehan ML, Berrios C, Ofoman O, Chang CC, Hauser BM, Feldman J, Roederer AL, Gregory DJ, Poznansky MC, Schmidt AG, Iafrate AJ, Naranbhai V, Balazs AB. Garcia-Beltran WF, et al. Among authors: sheehan ml. Cell. 2022 Feb 3;185(3):457-466.e4. doi: 10.1016/j.cell.2021.12.033. Epub 2022 Jan 6. Cell. 2022. PMID: 34995482 Free PMC article.
Maternal immune response and placental antibody transfer after COVID-19 vaccination across trimester and platforms.
Atyeo CG, Shook LL, Brigida S, De Guzman RM, Demidkin S, Muir C, Akinwunmi B, Baez AM, Sheehan ML, McSweeney E, Burns MD, Nayak R, Kumar MK, Patel CD, Fialkowski A, Cvrk D, Goldfarb IT, Yonker LM, Fasano A, Balazs AB, Elovitz MA, Gray KJ, Alter G, Edlow AG. Atyeo CG, et al. Among authors: sheehan ml. Nat Commun. 2022 Jun 28;13(1):3571. doi: 10.1038/s41467-022-31169-8. Nat Commun. 2022. PMID: 35764643 Free PMC article.
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant.
Garcia-Beltran WF, St Denis KJ, Hoelzemer A, Lam EC, Nitido AD, Sheehan ML, Berrios C, Ofoman O, Chang CC, Hauser BM, Feldman J, Gregory DJ, Poznansky MC, Schmidt AG, Iafrate AJ, Naranbhai V, Balazs AB. Garcia-Beltran WF, et al. Among authors: sheehan ml. medRxiv [Preprint]. 2021 Dec 14:2021.12.14.21267755. doi: 10.1101/2021.12.14.21267755. medRxiv. 2021. Update in: Cell. 2022 Feb 3;185(3):457-466.e4. doi: 10.1016/j.cell.2021.12.033. PMID: 34931201 Free PMC article. Updated. Preprint.
Heterologous sarbecovirus receptor binding domains as scaffolds for SARS-CoV-2 receptor binding motif presentation.
Hauser BM, Sangesland M, Lam EC, Denis KJS, Sheehan ML, Vu ML, Cheng AH, Balazs AB, Lingwood D, Schmidt AG. Hauser BM, et al. Among authors: sheehan ml. bioRxiv [Preprint]. 2023 Aug 22:2023.08.21.554179. doi: 10.1101/2023.08.21.554179. bioRxiv. 2023. Update in: ACS Infect Dis. 2024 Feb 9;10(2):553-561. doi: 10.1021/acsinfecdis.3c00483. PMID: 37662405 Free PMC article. Updated. Preprint.
COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residents.
Canaday DH, Oyebanji OA, White E, Keresztesy D, Payne M, Wilk D, Carias L, Aung H, St Denis K, Sheehan ML, Berry SD, Cameron CM, Cameron MJ, Wilson BM, Balazs AB, King CL, Gravenstein S. Canaday DH, et al. Among authors: sheehan ml. EBioMedicine. 2022 Jun;80:104066. doi: 10.1016/j.ebiom.2022.104066. Epub 2022 May 20. EBioMedicine. 2022. PMID: 35605428 Free PMC article.
Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunity.
Roederer AL, Cao Y, Denis KS, Sheehan ML, Li CJ, Lam EC, Gregory DJ, Poznansky MC, Iafrate AJ, Canaday DH, Gravenstein S, Garcia-Beltran WF, Balazs AB. Roederer AL, et al. Among authors: sheehan ml. medRxiv [Preprint]. 2024 Mar 7:2024.03.05.24303815. doi: 10.1101/2024.03.05.24303815. medRxiv. 2024. PMID: 38496628 Free PMC article. Preprint.
16 results